Intervention Review

Mistletoe therapy in oncology

  1. Markus Horneber1,*,
  2. Gerd Bueschel2,
  3. Roman Huber3,
  4. Klaus Linde4,
  5. Matthias Rostock5

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 16 APR 2008

Assessed as up-to-date: 3 FEB 2008

DOI: 10.1002/14651858.CD003297.pub2

How to Cite

Horneber M, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003297. DOI: 10.1002/14651858.CD003297.pub2.

Author Information

  1. 1

    Klinikum Nord, Medizinische Klinik 5-Schwerpunkt Onkologie/Haematologie, Nuernberg, Germany

  2. 2

    Vivantes Klinikum, Medizinische Klinik mit Schwerpunkt Haematologie und Onkologie, Berlin, Germany

  3. 3

    Universitätsklinikum Freiburg, Ambulanz für Naturheilkunde Medizinische Klinik 2, Freiburg, Germany

  4. 4

    Technische Universität München/Klinikum rechts der Isar, Institut für Allgemeinmedizin/Institute of General Practice, München, Germany

  5. 5

    Klinik fur Tumorbiologie, Klinik fur Internistische Onkologie, Freiburg, Germany

*Markus Horneber, Medizinische Klinik 5-Schwerpunkt Onkologie/Haematologie, Klinikum Nord, Prof.-Ernst-Nathan-Str. 1, Nuernberg, D-90419, Germany.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 APR 2008


  1. Current Version

    Mistletoe therapy in oncology

    Markus Horneber, Gerd Bueschel, Roman Huber, Klaus Linde and Matthias Rostock

    Version of Record online: 16 APR 2008 | DOI: 10.1002/14651858.CD003297.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Mistletoe Therapy in Oncology

    MA Horneber, G Bueschel, R Huber, K Linde, MA Richardson, M Rostock and G Kaiser

    Version of Record online: 22 JAN 2001 | DOI: 10.1002/14651858.CD003297